ID: ALA243042

Max Phase: Preclinical

Molecular Formula: C23H23N3OS

Molecular Weight: 389.52

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCNC(=S)Nc1ccc(OCCn2c3ccccc3c3ccccc32)cc1

Standard InChI:  InChI=1S/C23H23N3OS/c1-2-24-23(28)25-17-11-13-18(14-12-17)27-16-15-26-21-9-5-3-7-19(21)20-8-4-6-10-22(20)26/h3-14H,2,15-16H2,1H3,(H2,24,25,28)

Standard InChI Key:  GPNISCMHTGRQMU-UHFFFAOYSA-N

Associated Targets(non-human)

RAW 181 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 389.52Molecular Weight (Monoisotopic): 389.1562AlogP: 5.18#Rotatable Bonds: 6
Polar Surface Area: 38.22Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: 13.52CX Basic pKa: CX LogP: 5.33CX LogD: 5.33
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.45Np Likeness Score: -1.43

References

1. Kim YJ, Ryu JH, Cheon YJ, Lim HJ, Jeon R..  (2007)  Design and synthesis of urea and thiourea derivatives and their inhibitory activities on lipopolysaccharide-induced NO production.,  17  (12): [PMID:17467989] [10.1016/j.bmcl.2007.04.005]

Source